newsfilter
← Latest News
Business Wire·

Xeris Biopharma Reports Second Quarter 2026 Financial Results

Total revenue increased to over $92 million Net product revenue increased 34% year-over-year to over $91 million Recorlev net revenue increased 81% year-over-year to approximately $57 million Tightens full-year